Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF PROBIOTICS IN MEAT
Document Type and Number:
WIPO Patent Application WO/2015/048899
Kind Code:
A1
Abstract:
The present invention relates to the use of probiotics in meat. More particularly, the present invention relates to the use of probiotics for preserving the meat and for enhancing the consumer's health.

Inventors:
TISSERAND PIERRE (CA)
Application Number:
PCT/CA2014/050946
Publication Date:
April 09, 2015
Filing Date:
October 01, 2014
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
FAMIANTRO LUX (LU)
NUTRI QUAL INC (CA)
International Classes:
A23B4/22; A23L13/00; A23L33/135
Domestic Patent References:
WO2007003917A12007-01-11
Foreign References:
KR20040084167A2004-10-06
EP2292731A12011-03-09
Other References:
R. AMIN;: "Effect of Bio Preservation as a Modern Technology on Quality Aspects and Microbial Safety of Minced Beef", GLOBAL JOURNAL OF BIOTECHNOLOGY & BIOCHEMISTRY, vol. 7, no. 2, 2012, pages 38 - 49, XP055337545
A SALEM;: "Bio-Preservation Challenge for Shelf-Life and Safety Improvement of Minced Beef", GLOBAL JOURNAL OF BIOTECHNOLOGY & BIOCHEMISTRY, vol. 7, no. 2, 2012, pages 50 - 60, XP055337546
SPARO ET AL.: "Bio-preservation of ground beef meat by Enterococcus faecalis CECT7121", BRAZ J MICROBIOL., vol. 44, no. 1, 2013, pages 43 - 49, XP055337547
F. BARUZZI ET AL.: "Antimicrobial compounds produced by Bacillus spp. and applications in Food", SCIENCE AGAINST MICROBIAL PATHOGENS: COMMUNICATING CURRENT RESEARCH AND TECHNOLOGICAL ADVANCES, 2011, pages 1102 - 1111, XP055255435
See also references of EP 3060061A4
Attorney, Agent or Firm:
ROBIC LLP (Bloc E - 8th Floor1001 Square-Victori, Montréal Québec H2Z 2B7, CA)
Download PDF:
Claims:
CLAIMS

1 - Use of a probiotic in meat.

2- Use of a probiotic in meat for reducing the proliferation of and/or kill other bacteria.

3- Use of a probiotic in meat for increasing the meat's shelf-life.

Description:
USE OF PROBIOTICS IN MEAT

Field of the invention:

The present invention relates to the use of probiotics in meat. More particularly, the present invention relates to the use of probiotics for preserving the meat and for enhancing the consumer's health.

Background of the invention:

It is well known in the art that preservation of the meat, once cut from the animal, until eaten by the consumer is a serious issue. The cold chain must not be interrupted, the transport must be fast. Serious hygienic measures are put in place in order to reduce the amount of exogenous microorganisms in contact with the meat. Some methods are known for drying the meat or fermenting the meat (See Luc de Vuyst et al, Probiotics in fermented sausages, in Meat Science, Volume 80, Issue 1 , September 2008, p75-78, Elsevier; Renata Ernlund Freitas de Macedo et al, Probiotic Meat Products, in Probiotic in Animals, Chapter 5, book edited by Everlon Cid Rigobelo, 2012, both incorporated by reference).

However, most of these conventional systems are not provided with an efficient protection and conservation of the meat.

Hence, in light of the aforementioned, there is a need for an improved method of preservation of the meat, which by virtue of the use of probiotics, would be able to overcome some of the above-discussed prior art problems.

Summary of the invention:

The object of the present invention is to provide the use of probiotics in meat.

The object of the present invention is to provide the use of probiotics in meat to reduce the proliferation of and/or kill other bacteria, including but not limited to pathogenic bacteria (such as coliforms, E.coli, Enterobacteria, Salmonella, Listeria). According to yet another aspect of the present invention, there is also provided a use of probiotics in meat to increase the meat or meat products' shelf- life.

According to yet another aspect of the present invention, there is also provided a use of probiotics in meat to enhance the nutritional quality of the meat.

According to yet another aspect of the present invention, there is also provided a use of probiotics in meat to interact with prebiotics.

According to yet another aspect of the present invention, there is also provided a use of prebiotics with the probiotics described therein.

According to yet another aspect of the present invention, there is also provided a use of probiotics in meat to provide a source of vitamin K in the consumer's gut.

According to yet another aspect of the present invention, there is also provided a composition of probiotics and a buffer.

According to yet another aspect of the present invention, there is also provided a composition of probiotics, prebiotics and a buffer.

In accordance with the present invention, the above object is achieved, as will be easily understood, with probiotics and optionally with prebiotics such as the ones described herein.

The objects, advantages and other features of the present invention will become more apparent upon reading of the following non-restrictive description of preferred embodiments thereof, given for the purpose of exemplification only, with reference to the accompanying figures.

Brief description of the figures:

Figure 1 represents a shelf-life experiment for fresh chicken breasts performed for coliform bacteria. ( represents the sample without probiotics; -■-represents the sample with combination A of probiotics; represents the sample with combination B of probiotics).

Figure 2 represents a shelf-life experiment for fresh chicken breasts performed for E.coli bacteria. ( represents the sample without probiotics; -■-represents the sample with combination A of probiotics; represents the sample with combination B of probiotics).

Figure 3 represents a shelf-life experiment for fresh chicken breasts performed for Enterobacteria. ( ~~ represents the sample without probiotics; -■-represents the sample with combination A of probiotics; represents the sample with combination B of probiotics).

Description of the embodiments:

Definitions:

Meat includes meat, meat products and meat end products.

Meat includes but is not limited to the flesh of mammalian species (such as cattle, beef, veal, pig, lamb, sheep, goat, pork, rabbit, etc.), fish, seafood (including crustacean, mollusk, etc), poultry (including chicken, turkey, duck, etc), game (birds, deer, moose, caribou, bison, boar, partridge, guineafowl, etc), other animals (including ostrich, emu, kangaroo, crocodile, frogs, snails, snakes, etc), and tissue made of animal proteins. Meat includes fresh, raw, sushi, or cooked meat.

Meat products include edible products for animals or humans, made of meat, such asboneless cuts of meat, or cuts of meat with bone, offal, trimmings, meat byproducts (skin, mechanically separated meat, bones, etc.).

Meat end products include processed meat products (deli meats, ham, sausage, meat patty, breaded meat products, prepared meals, ready-to-eat products, mechanically separated meat and other processed meat products. Probiotics are bacteria associated with beneficial effects for humans and animals which are introduced in food. The beneficial effects of food with added live microbes (probiotics) on human or animal health are being increasingly promoted by health professionals. It has been reported that these probiotics can play an important role in immunological, digestive and respiratory functions.

Probiotics are vegetative bacteria or live bacteria, which can also form spores, under stressing conditions (temperature, pH, light, etc). Bacterial spores are dormant life forms which can exist in a dehydrated state indefinitely, until better conditions are available, such as in the gut, and recover their vegetative form. The probiotics of the invention contain about 40-20% vegetative bacteria and about 60- 80% spores. In one aspect, they contain 30% vegetative bacteria and 70% spores. Cooking of the meat containing the probiotics of the invention will kill most of the vegetative bacteria, especially if they did not become spores, and will kill about half of the spores. Probiotics and prebiotics are used in an effective amount to deliver the desired result, but low enough to avoid toxic effect for the human or animal. Health Canada orders to use a fixed amount of probiotics of one billon, per eaten portion, such as one billion of live bacteria after the meat is cooked. The effective amount of probiotics to be added to the raw meat is about 3 billion of probiotics per portion in order to keep about 1 billion of probiotics in the cooked portion delivered to and/or eaten by the consumer. The total bacteria may be a mix of different bacteria.

Probiotics are provided in powder (sachets, capsules, tablets, pellets, freeze dried pellets), cream, gel or liquid (in bottles or vials). They can be mixed with various ingredients.

Amongst probiotic strains, probiotic strains that are not pathogenic for animals and/or humans may be used such as Bacilli strains (Bacillus subtilis, Bacillus clausii, Bacillus cereus, Bacillus coagulens, Bacillus Licheniformis, etc. (examples are found in Bacillus Spores as Probiotics and Food Supplements, in Molecular biological methods for Bacillus, Edited by Colin R. Harwood and Simon M. Cutting, 1990, John Wiley & Sons (Chichester, UK) incorporated by reference), Lactobacilli, Clostridia, Bifidobacteria, Enterococci, Streptococci, Escherichia strains.

Prebiotics are non-digestible food ingredients that stimulate the growth and/or activity of bacteria in the digestive system in ways claimed to be beneficial to health. In one embodiment, they are not pathogenic for humans and/or animals. Prebiotics include oligosaccharides or polysaccharides with a chain of 2 to 20 sugar units, such as inulin.

Consumers include animals and humans who eat meat or meat products.

Buffer is water or any other suitable liquid, known and used in the industry.

The liquid can be Butterfield's Buffered Phosphate Diluent, or oil. For instance, a composition of probiotic strain and water may be prepared.

The use of probiotics of the invention in meat helps reducing the proliferation of and/or killing other bacteria, including but not limited to pathogenic bacteria (Conforms such as E.coli, Enterobacteria such as salmonella) in said meat.

It is quite counterintuitive to add bacteria in the meat: the goal of best industry practices has always been to reduce the bacterial load rather than to augment the bacterial load.

Adding probiotics in meat, such as one billon probiotics per serving of end product, allows saturation of the bacteria already present in the meat. This saturation has an inhibitory effect on the growth and/or life of all bacteria present in the meat.

Adding a large number of probiotic bacteria per food serving quickly saturates the medium. The bacterial population being quite large, a growth inhibition of the pathogenic bacteria is observed.

Bacteria naturally produce antibiotics, to kill competitive bacteria (US 4931398 describes the use of a Bacillus Strain to prevent the growth of aflatoxin- producing fungi in cereals and nuts. Bie, Xiaomei et al (Food science and Technology International, 2006, volume 12, (3) 189, both herein incorporated by reference) describe an antimicrobial substance produced by Bacillus subtilis which is used for the preservation of milk; both incorporated by reference). It allows the probiotic to reduce proliferation and to inhibit the growth of other bacteria, either pathogenic or not.

Probiotic bacterial strains do not alter the meat's taste, smell and/or visual aspect. An organoleptic study was conducted throughout the product's life. No change was observed neither in its odour, taste or visual aspect. In one aspect, consumers were invited to taste both products, they could not make the difference.

It is known to add bacteria or yeasts in bakery or in fermented meat, either to acidify the product or to allow fermentation. However the probiotic strains of the invention do not induce acidification or fermentation.

The probiotics of the invention are preferably not used with dry meat.

Meat is kept at a temperature according to industry practice, preferably between about 0° and about 8Ό and more preferably between about 0° and about 4Ό. This prevents bacteria from having an importan t cellular activity and hence reduces bacterial growth.

Some bacterial strains, including but not limited to some probiotic strains, are thermosensitive.

In one embodiment, the probiotic strains of the invention are heat-resistant.

In one embodiment, the probiotic strains of the invention are not pathogenic for humans and/or animals.

In one embodiment, the probiotic strain of the invention is Bacillus subtilis R0179 deposited at the Pasteur Institute (France) under No CNCM 1-3471 which is a heat-resistant probiotic, approved for use in foods and beverages. It obtained GRAS (Generally Regarded As Safe) status, a designation created by the US Food and Drug Administration. It has the ability to revert to a spore form when under environmental stress (pH, temperature, activity water, salt, antibiotics...) while reverting to the vegetative form once back in appropriate conditions such as those found in the stomach and the gastrointestinal tract. This feature allows this probiotic to be added in meat and also allows for the use of a "source of probiotic" claim for marketing purposes.

The reason why the Bacillus' heat-resistance and spore form are interesting features is that it is stable regardless of its environment, and its protein layer provides an excellent protection from deep-freezing, thawing, salt, pH changes, and especially cooking. For the probiotic claim to be allowed, the bacteria must still be alive when going through the consumer's digestive tract. If the bacteria are destroyed during cooking, they become less useful.

A series of cooking tests were conducted on various meat products to ensure that the probiotic was viable as well as to figure out the initial quantity of probiotic to put onto or into the products. Also, even if the bacteria are sold as spores, about 30% of these are still in a vegetative form (i.e., not in the form of spores). It is a complex process, but it is not because the bacteria are subjected to a temperature stress during their "preparation" that 100% of bacteria will end up in the form of spores.

That is why this parameter needs to be taken into account in the survival rate calculations, because all vegetative bacteria will die. Up to 80 Ό, the other bacteria are either barely or not affected by the heat. Beyond this temperature, bacterial destruction begins.

When the Bacillus is in its spore form, it does not extend the shelf-life of the product. Given that the spore has a neutral impact on its environment, the bacterium is protected, but it has no cellular activity and does not interact with its surroundings. The bacteria which are in their vegetative state do however interact with their environment and extend the product shelf-life.

Then once the meat is cooked and eaten, the probiotics find better conditions (temperature, pH etc), the spores return to the vegetative form, the spore's coat is broken and/or removed and the probiotics are active in the human or animal digestive system. In one embodiment, a non-heat-resistant probiotic strain is used: as it is in its vegetative form, it can inhibit the growth of other bacteria. The way the vegetative bacterium strain is picked depends upon the type of food that needs protecting, as there are many sorts of probiotic bacteria, and each of them have their own specific strains. For example, Bifidobacterium longum R0175 produces an antibiotic which enables it to resist and kill E. coli. This is particularly interesting for beef products, as E. coli 0157H7 is the most dangerous pathogen for this type of products.

Therefore, for each food type, a specific strain of probiotic or a combination of strains of probiotic will be used to minimize food safety risks and to keep the nutritional advantages of probiotics. In one embodiment, a heat-resistant probiotic is used to keep probiotic properties after the meat is cooked thanks to the sporulation of the probiotic, while a non-heat-resistant probiotic and/or the vegetative form of the heat-resistant probiotic is used to reduce the proliferation of and/or kill other bacteria, including but not limited to pathogenic bacteria (E.coli, listeria, salmonella).

Probiotics may be used with co-ingredients such as dyes, enzymes, vitamins, mineral supplements, anti-oxydants, preservatives, fats, fibers, omega-3 products etc.

Use of the probiotics of the invention can be made through different processes including but not limited to the following ones:

- They can be blended with the meat;

- They can be injected in the meat, or in the brine;

- They can be vaporized on the meat or meat's product's surface, optionally with a spray nozzle;

- They can be used in a lyophilized form or in fine droplets;

- They can be used optionally with spices.

The following examples are provided by way of illustration, and they are not intended to be limiting of the present invention. Example 1 : Plaque for bacterial count

1. Pre-environmental control procedures:

The manipulations are performed in a working area that is sanitized and sterilized with rubbing alcohol. All items used for manipulations must be sterile (knives and meat cutting boards, use of sterile gloves possible, otherwise no physical contact with meat). A burner is turned on, whose flame colour should be blue at its base (more intense heat), allowing heat to spread over a radius of at least 10 cm around which exposed products and equipment (scale, samples, Petrifilm™, pipettes, etc.) are handled. a. Storage:

Unopened packages are stored at a T ° < 8 Ό and th e closed packages are kept at a T°= 4 Ό, at a relative humidity of 50 %. b. Preparing a sample:

For every meat, about 8-15 g of the raw meat sample is prepared. In one aspect, 1 1 g is prepared.

A concentration of 1 billion probiotics of Bacillus subtilis R0179 per serving of end product diluted in 1 ml of sterile water, or 1 ml of sterile water for control samples is sprayed on the sample.

Since the tested sample weighs 1 1 g, it is necessary to calculate the correct dilution to perform in order to get the same ratio of probiotics per serving. If the portion weighs 100 g, then x = (1 * 10 9* 1 1/100); x = 1 10 * 10 6

The samples are kept refrigerated at T - 4 Ό until the date of sampling.

Buffer solutions containing citrate, bisulfite or sulfate thiosulfate, should not be used as they may inhibit probiotic growth.

According to the current method, the pH is adjusted between 6.6 and 7.2; for acid products, 1 N NaOH is used; for alkaline products, 1 N HCI is used. c. Inoculation :

The samples are put in the stomacher for 2 min to extract the bacteria. The plate is put on a flat surface. The top film is lifted. The pipette is held perpendicular to the plate, and 1 ml of sample is placed in the center of the bottom film. The top film is let fallen back on the bottom film. (It must not be scrolled back on). A spreader, ribbed side down, is put on the top film of the inoculum. A slight pressure is applied on the spreader to spread the inoculum over the circular surface. The spreader must not be twisted or slided. The spreader is lifted. It takes at least 1 min while the gel solidifies.

Dilutions can be made in order to get a better reading. d. Incubation:

The plates are incubated - transparent side up - in stacks of 20 plates or less. If necessary, the incubator is moistened in order to minimize moisture loss.

AOAC Official Method 990.12 -> requires incubation at 35 ± 1 for 48 h ± 3 h for the total count.

AOAC Official Method 991 .14 -> requires incubation at 35 ± 1 for 48 h ± 3 h for E. coli and 24 h ± 3 h for coiiforms.

AOAC Official Method 2003.01 required incubation at 35 ± 1 for 24 h ± 3 h for Enterobacteria. e. Interpretation:

The total count can be performed on a regular colony counter or with a magnifier with light after 48 hours. They appear as a pink dot.

After 48 h for E coli and 24 h for coiiforms, the count can be performed on a regular colony counter or with a magnifier with light. They appear as blue colonies (for E. coli) or red colonies (for coiiforms) with gas bubbles for coiiforms.

After 24 h for Enterobacteria, the count can be performed on a regular colony counter or with a magnifier with light. They appear as yellow colonies. Example 2 - Shelf-life experiment on raw meat

Since meat sold to consumers must abide by Health agencies' regulations and contain a fixed limited number of pathogenic bacteria, 6 shelf-life tests were conducted on beef meat and 6 more on chicken meat with Bacillus subtilis R0179 to check the amount of bacteria in the meat. For each of these tests, 6 samples were prepared, which were tested after 0 day, 1 day, 2 days, 3 days, 4 days and 5 days.

For each sample, 3 types of microbiology tests were conducted:

• Total aerobic count

· E. coli / coliform count

• Enterobacteria count

Regarding the total aerobic count, these values must be read in view of the fact that both the endogenous bacteria and the added probiotics grow in this environment. Since probiotics were inoculated on the sample and since said probiotics then increase in number, the result for the total aerobic count is higher than usual. This is why these results are not used in the table below.

However, in order to check whether the addition of probiotics influences the growth of various specific bacteria, such as Conforms (e.g. E. Coli), and /or Enterobacteria (e.g. Salmonella), that reduce the shelf-life of the products, the average results were compared through a statistical method: Student's f-test.

The assumption is that, on average, once the shelf-life test is complete, the samples that were inoculated with the probiotics at a concentration of 1 billion per serving show a count equal to that of a product which was not inoculated with probiotics. Table 1 .

Student's f-test without

Coliform probiotics with probiotics

Average 12231 .9512 3810.238095

Variance 91 1942950 68242702.44

Observations 40 41

Weighted

Variance 484884800

Degree of

freedom 79

Value of t

Critical value of

t 10.7581906

Bilateral for n=

79 and

alpha=0,05 1 .9905

Conclusion Discarded without

E. coli probiotics with probiotics

1642.43902 825.952381

73982686.1 21999795.3

40 41

47670358.6

79

Value of t

Critical value of 3.33308246

t

bilateral for

n=79

and alpha=0,05 1 .9905

Conclusion Discarded without

Enterobacteria probiotics with probiotics

27130 12401 .6667

1415530462 440642520 40 41

922068664

79

Value of t

Critical value of

t 13.6721666

bilateral for

n=79

and alpha=0,05 1 .9905

Conclusion Discarded

In practice, a high critical value of t (above 2.5) suggests that the difference observed between the value of t and the critical value of t is much greater than the sole variability strictly due to random sampling. In this case, the value of t for all three categories is greater than 1 .99 (10.76, 3.33, 13.67), which tends to suggest differences between the bacterial count averages obtained for the various shelf-life tests, those with and those without probiotics inoculations (coliform, E. coli and Enterobacteria).

The hypothesis that the difference between the averages is zero must be rejected, meaning that the averages are not identical. In conclusion, the inoculation of probiotics into meat products has reduced the growth of other bacteria (coliform, E. coli and Enterobacteria).

Example 3 - Shelf-life experiment for raw chicken breasts

The tests were performed by an independent accredited laboratory, with Bacillus subtilis R0179.

Tests were performed on 3 types of bacteria: coliform bacteria, E. coli and enterobacteria.

The bacterial counts were recorded after 1 , 1 1 , 12 and 13 days.

3 types of products were used: - chicken breasts without probiotics ( )

- chicken breasts with a first combination of probiotics (combination A:

Bacillus subtilis R0179) ( "■")

- chicken breasts with a second combination of probiotics (combination B:

Bacillus subtilis R0179 and Bifidobacterium long urn 0175) ( )

An inoculum of 5% of probiotics in weight, comprising water and probiotics, was added to the total weight of chicken breast. It represents three billions of bacteria on a raw product.

The results are shown in Table 2.

Table 2.

Chicken breast with combination B of probiotics D 1 D 1 1 D 12 D 13

Coliform 20 10 10 10

E. coli 20 10 10 10

Enterobacteria 35 5 25 20

The results are shown in CFU/g (Colony Forming Unit per gram, i.e. the number of bacterial colonies that are present and alive per gram of product).

The results are presented in the form of a graph in Figures 1 -3, with the bacterial population in CFU/g on the vertical axis and the elapsed number of days since testing started on the horizontal axis.

The results shown for each test (e.g. D 1 1 vs. D 12) may vary due to the fact that each test was performed on a different chicken breast whose initial bacterial populations were different.

As the graphs clearly show, the ■ and lines, i.e. those depicting chicken breasts with probiotics, indicate a bacterial count close to zero (0) after 13 days.

The following Table 3 shows the trends for each line:

For the breast without probiotic, the exponents are positive, which means that the bacterial population is increasing.

On the contrary, when it comes to the two samples with probiotics, the value of the exponents is negative, which indicates that the bacterial population is not increasing, it is decreasing, which means that those bacterial populations are being destroyed.

Conclusion:

Adding the probiotics of the invention in meat products has prolonged the products' shelf-life. The study shows that the average shelf-life of fresh chicken breasts was extended from 10 to 13 days, which represents a 30 % increase of the average shelf-life.

The probiotics also reduced the products' bacterial populations: the number of pathogenic bacterial populations found in the product after 13 days was lower than the initial population count. These results prove the dual role that probiotics play in prolonging a fresh meat product's shelf-life: on one hand, probiotics are a growth inhibitor, which means that they keep the tested pathogenic bacteria from spreading, and on the other hand, probiotics destroy said pathogenic bacteria as the number of bacterial colonies is reduced.

Example 4 - Shelf-life experiment on ham

The experiment was conducted over 6 weeks.

Sample

description B. subtilis 0179

Concentration (cfu/lOOg.

Shelf life (days) serving) Survival rate (%) Inoculation dose (0) 3.00E+08 100.00

Ham (with

1 week 5.25E+08 174.85 Bacillus 0179

4 weeks 4.96E+08 165.48 only)

5 weeks 2.33E+07 7.78

6 weeks 1.70E+08 56.55

Ham (with Inoculation dose (0) 3.00E+08 100.00

Bacillus R0179

1 week 4.13E+08 137.54 and Bifido

4 weeks 3.32E+08 110.79 R0175)

5 weeks 1.97E+07 6.56

6 weeks 2.30E+08 76.67

The probiotic, Bacillus subtilis R0179, survives very well to the process.

Several modifications could be made to the above-described embodiments of the invention, without departing from the scope of the present invention, as can be easily understood by a person skilled in the art.

The scope of the claims should not be limited by the preferred embodiments set forth in the examples but should be given the broadest interpretation consistent with the description as a whole.